Skip to main navigation Skip to search Skip to main content

Triggering through CD40 promotes interleukin-4-induced CD23 production and enhanced soluble CD23 release in atopic disease

  • Robin L.K. Paterson
  • , Gideon Lack
  • , Jeanne M. Domenico
  • , Guy Delespesse
  • , Donald Y.M. Leung
  • , Terri H. Finkel
  • , Erwin W. Gelfand
  • Natl. Jewish Ctr. Immunol. Resp. M.
  • University of Montreal
  • Unknown
  • National Jewish Medical and Research Center

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

The pathogenesis of atopic disease is closely linked to the overproduction of IgE. CD23 and CD40 are two cellular receptors involved in the regulation of IgE production and both receptors are elevated in atopic disease. We have examined the role of CD40 in the regulation of CD23 and soluble CD23 production in healthy and atopic donors. Triggering of the B cell CD40 receptor directly enhances interleukin (IL)-4-mediated up-regulation of CD23 at both the protein and the mRNA level. When atopic donors were studied, the synergistic effect of CD40 triggering on the IL-4-induced up-regulation of CD23 and soluble CD23 (sCD23) was enhanced and there was a relative skewing toward production of sCD23. These studies implicate the CD40 receptor in the hyperproduction of CD23 and sCD23 in atopic disease and suggest that abnormalities may exist in the cellular pathways leading to sCD23 production.

Original languageEnglish
Pages (from-to)1979-1984
Number of pages6
JournalEuropean Journal of Immunology
Volume26
Issue number9
DOIs
StatePublished - 1996
Externally publishedYes

Keywords

  • Atopic disease
  • B cell
  • CD23
  • CD40

Fingerprint

Dive into the research topics of 'Triggering through CD40 promotes interleukin-4-induced CD23 production and enhanced soluble CD23 release in atopic disease'. Together they form a unique fingerprint.

Cite this